The attached study published in the Lancet regarding long-term clinical effects of recovered COVID-19 patients confirms what we have seen in our office over the past several months - increased rates of hair loss.
In addition to fatigue, muscle weakness, altered smell, insomnia, and depression, hair loss affects 22% of the patients surveyed in this published trial.
I believe the vast majority are a telogen effluvium - a disruption in our hair cycle that can occur with any phyisical, emotional or psychological stress on our body. It typically presents 3-6 months after the stress (in this case COVID-19) and can result in a dramatic loss of hair.
The good news is most patients can recover the majority of lost hair over 6-12 months. Minoxidil, PRP, LLLT and finasteride can help speed up the recovery.
Any patient with sudden hair loss should be evaluated by their dermatologist to help establish the underlying cause and help create a treatment plan.
https://www.thelancet.com/action/showPdf?pii=S0140-6736(20)32656-8
You Might Also Enjoy...
These are the first two CME articles on hair transplantation to ever be published in the leading peer reviewed journal in our field. I am proud to be one of its authors.
During the American Academy of Dermatology (AAD) virtual meeting experience, I was happy to participate in this very informative session on innovative therapeutic tools to slow hair loss and increase hair growth.
JAK inhibitors approved now by the FDA represent an important new treatment option for our patients with widespread alopecia areata.
More promising news in the treatment of alopecia areata. More clinical trials are needed to ensure safety and efficacy but very promising.
This analysis demonstrates that there is no increased risk of cancer when using spironolactone.
For some highly motivated patients, a combination of two therapies can be effective in helping hair loss.
